This difference may explain the more abundant infiltration of TILs in the EPHA5-Mut TME than in the EPHA5-WT TME, as these mutated neoantigens can be recognized by TILs and induce tumor-specific immune responses. The gene discussed is EPHA5; the disease is neoplasm.